DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Knoebl P, Cataland S, Peyvandi F. , et al.
Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study.
J Thromb Haemost 2020;
18 (02) 479-484
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.